After
I've published a few articles about safe dividend stocks and stocks with high
cash and low debt ratios, I come back to growth.
Growth is good because it grows the value of your
assets too. I ever told that only a growing stock is good but you can only make
money with growth stocks if you pay reasonable prices for them.
The market is highly valuated, that's news from the
recent quarters and more than true. With P/E multiples above 20, you need high
growth to justify this values.
Today, I've created a screen for you that are based on
momentum growth. I've discovered stocks with double digit earnings and sales
growth.
These are my main criteria:
- Market Cap over $10 billion
- Positive Dividend Yield
- Debt-To-Equity Ratio under 0.5
- 5Y Forecasted Earnings Growth over 5%
- Quarter over Quarter Sales Growth over 10%
- Quarter over Quarter Earnings Growth over 10%
- Only US Home Base
Nineteen stocks fulfilled these criteria of which none yield over 2.5 percent in dividend. That's not much but for growth you can waive a small part of your yield.
 |
| Green money should come into your portfolio |
6 Top Dividend Momentum Stocks are...
BlackRock (NYSE:BLK) has a market capitalization of $55.23 billion. The company employs 11,500 people, generates revenue of $10,180.00 million and has a net income of $2,951.00 million. BlackRock’s earnings before interest, taxes, depreciation and amortization (EBITDA) amounts to $4,167.00 million. The EBITDA margin is 40.93 percent (the operating margin is 37.89 percent and the net profit margin 28.99 percent).
Financial Analysis: The total debt represents 3.32 percent of BlackRock’s assets and the total debt in relation to the equity amounts to 27.62 percent. Due to the financial situation, a return on equity of 11.31 percent was realized by BlackRock. Twelve trailing months earnings per share reached a value of $18.18. Last fiscal year, BlackRock paid $6.72 in the form of dividends to shareholders.
Market Valuation: Here are the price ratios of the company: The P/E ratio is 18.30, the P/S ratio is 5.43 and the P/B ratio is finally 2.12. The dividend yield amounts to 2.32 percent and the beta ratio has a value of 1.44.
 |
| Long-Term Stock Price Chart Of BlackRock (BLK) |
 |
| Long-Term Dividend Payment History of BlackRock (BLK) |
 |
| Long-Term Dividend Yield History of BlackRock (BLK) |
Do you like this article? If yes, please support us and hit the button for a Facebook Like, make a tweet or post a comment in the Dividend Yield
community! Thank you so much, we really appreciate it.
Automatic Data Processing (NASDAQ:ADP) has a market capitalization of $40.56 billion. The company employs 61,000 people, generates revenue of $12,206.50 million and has a net income of $1,502.60 million. Automatic Data Processing’s earnings before interest, taxes, depreciation and amortization (EBITDA) amounts to $2,559.10 million. The EBITDA margin is 20.97 percent (the operating margin is 18.09 percent and the net profit margin 12.31 percent).
Financial Analysis: The total debt represents 6.82 percent of Automatic Data Processing’s assets and the total debt in relation to the equity amounts to 32.75 percent. Due to the financial situation, a return on equity of 23.37 percent was realized by Automatic Data Processing. Twelve trailing months earnings per share reached a value of $3.11. Last fiscal year, Automatic Data Processing paid $1.83 in the form of dividends to shareholders.
Market Valuation: Here are the price ratios of the company: The P/E ratio is 27.11, the P/S ratio is 3.32 and the P/B ratio is finally 6.07. The dividend yield amounts to 2.28 percent and the beta ratio has a value of 0.85.
 |
| Long-Term Stock Price Chart Of Automatic Data Processing (ADP) |
 |
| Long-Term Dividend Payment History of Automatic Data Processing (ADP) |
 |
| Long-Term Dividend Yield History of Automatic Data Processing (ADP) |
CVS Health (NYSE:CVS) has a market capitalization of $94.55 billion. The company employs 130,000 people, generates revenue of $126,761.00 million and has a net income of $4,600.00 million. CVS Health’s earnings before interest, taxes, depreciation and amortization (EBITDA) amounts to $9,931.00 million. The EBITDA margin is 7.83 percent (the operating margin is 6.34 percent and the net profit margin 3.63 percent).
Financial Analysis: The total debt represents 18.74 percent of CVS Health’s assets and the total debt in relation to the equity amounts to 35.33 percent. Due to the financial situation, a return on equity of 12.17 percent was realized by CVS Health. Twelve trailing months earnings per share reached a value of $4.09. Last fiscal year, CVS Health paid $0.90 in the form of dividends to shareholders.
Market Valuation: Here are the price ratios of the company: The P/E ratio is 19.97, the P/S ratio is 0.75 and the P/B ratio is finally 2.54. The dividend yield amounts to 1.35 percent and the beta ratio has a value of 0.96.
 |
| Long-Term Stock Price Chart Of CVS Health (CVS) |
 |
| Long-Term Dividend Payment History of CVS Health (CVS) |
 |
| Long-Term Dividend Yield History of CVS Health (CVS) |
If you would like to receive more dividend stock ideas, you should subscribe to my free e-mail list.
Alternatively, you can follow me on Facebook or Twitter.
Starbucks Corporation (NASDAQ:SBUX) has a market capitalization of $58.56 billion. The company employs 182,000 people, generates revenue of $14,892.20 million and has a net income of $8.80 million. Starbucks Corporation’s earnings before interest, taxes, depreciation and amortization (EBITDA) amounts to $2,862.90 million. The EBITDA margin is 19.22 percent (the operating margin is -2.19 percent and the net profit margin 0.06 percent).
Financial Analysis: The total debt represents 11.28 percent of Starbucks Corporation’s assets and the total debt in relation to the equity amounts to 29.00 percent. Due to the financial situation, a return on equity of 0.17 percent was realized by Starbucks Corporation. Twelve trailing months earnings per share reached a value of $0.31. Last fiscal year, Starbucks Corporation paid $0.89 in the form of dividends to shareholders.
Market Valuation: Here are the price ratios of the company: The P/E ratio is 255.45, the P/S ratio is 3.93 and the P/B ratio is finally 13.10. The dividend yield amounts to 1.33 percent and the beta ratio has a value of 0.91.
 |
| Long-Term Stock Price Chart Of Starbucks Corporation (SBUX) |
 |
| Long-Term Dividend Payment History of Starbucks Corporation (SBUX) |
 |
| Long-Term Dividend Yield History of Starbucks Corporation (SBUX) |
Estee Lauder (NYSE:EL) has a market capitalization of $29.28 billion. The company employs 42,400 people, generates revenue of $10,968.90 million and has a net income of $1,209.10 million. Estee Lauder’s earnings before interest, taxes, depreciation and amortization (EBITDA) amounts to $2,217.30 million. The EBITDA margin is 20.21 percent (the operating margin is 16.66 percent and the net profit margin 11.02 percent).
Financial Analysis: The total debt represents 17.07 percent of Estee Lauder’s assets and the total debt in relation to the equity amounts to 34.84 percent. Due to the financial situation, a return on equity of 33.72 percent was realized by Estee Lauder. Twelve trailing months earnings per share reached a value of $3.06. Last fiscal year, Estee Lauder paid $0.78 in the form of dividends to shareholders.
Market Valuation: Here are the price ratios of the company: The P/E ratio is 25.09, the P/S ratio is 2.67 and the P/B ratio is finally 7.63. The dividend yield amounts to 1.04 percent and the beta ratio has a value of 1.10.
 |
| Long-Term Stock Price Chart Of Estee Lauder (EL) |
 |
| Long-Term Dividend Payment History of Estee Lauder (EL) |
 |
| Long-Term Dividend Yield History of Estee Lauder (EL) |
Allergan (NYSE:AGN) has a market capitalization of $49.63 billion. The company employs 11,700 people, generates revenue of $6,300.40 million and has a net income of $1,272.50 million. Allergan’s earnings before interest, taxes, depreciation and amortization (EBITDA) amounts to $2,184.60 million. The EBITDA margin is 34.67 percent (the operating margin is 28.72 percent and the net profit margin 20.20 percent).
Financial Analysis: The total debt represents 20.37 percent of Allergan’s assets and the total debt in relation to the equity amounts to 33.33 percent. Due to the financial situation, a return on equity of 20.63 percent was realized by Allergan. Twelve trailing months earnings per share reached a value of $4.37. Last fiscal year, Allergan paid $0.20 in the form of dividends to shareholders.
Market Valuation: Here are the price ratios of the company: The P/E ratio is 38.26, the P/S ratio is 7.88 and the P/B ratio is finally 7.69. The dividend yield amounts to 0.12 percent and the beta ratio has a value of 0.75.
 |
| Long-Term Stock Price Chart Of Allergan (AGN) |
 |
| Long-Term Dividend Payment History of Allergan (AGN) |
 |
| Long-Term Dividend Yield History of Allergan (AGN) |
Do you like this article? If yes, please support us and hit the button for a Facebook Like, make a tweet or post a comment in the Dividend Yield
community! Thank you so much, we really appreciate it.
 |
| My statement of the day |
Please share or donate to support our work. Thank you so much for reading. Here is the full list of the momentum stocks.
 |
| 5 Year Stock Performance Of The Momentum Stocks (click to enlarge) |
 |
| List of Dividend Momentum Stocks (Click to enlarge) |
--------------------
*I am long ADP. I receive
no compensation to write about these specific stocks, sector or theme. I don't
plan to increase or decrease positions or obligations within the next 72 hours.
For the other stocks: I
have no positions in any stocks mentioned, and no plans to initiate any
positions within the next 72 hours. I receive no compensation to write about
any specific stock, sector or theme.